Woden Venture Capital (Woden) plans to acquire biotechnology company ACCUM Therapeutics Inc. for C$4.5m ($3.6m).
Both entities involved in the acquisition are based in Canada.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
"German drug discovery company Evotec plans to acquire Aptuit from Welsh, Carson, Anderson & Stowe (WCAS) for $300m."
German drug discovery company Evotec plans to acquire Aptuit from Welsh, Carson, Anderson & Stowe (WCAS) for $300m.
Aptuit is a pharmaceutical services provider, while WCAS is a private equity firm. Both companies are based in the US.
The acquisition will create new business opportunities for Evotec and strengthen its market position.
GlobalData Strategic Intelligence
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
